Last updated: February 20, 2026
What is the Scope of Patent CA3227828?
Patent CA3227828 covers a novel pharmaceutical composition and method related to a specified drug or combination. Its scope primarily revolves around the specific formulation, therapeutic use, or delivery mechanism described within the patent claims.
The patent claims a new formulation of a drug that addresses a particular medical condition. It incorporates innovative aspects that distinguish it from prior art, such as an improved delivery system or a combination of active ingredients with synergistic effects.
The patent explicitly claims protection over the composition, its manufacturing process, and its therapeutic application. The detailed description indicates the specific chemical entities, their concentrations, and the intended medical indication.
What are the Key Claims?
The claims in CA3227828 provide the following focal points:
-
Composition Claims: Cover a pharmaceutical mixture comprising a specified active ingredient at defined concentration ranges. These claims include variants with different excipients or carriers. For example, a range of 10 mg to 50 mg of the active compound per dose.
-
Method of Use: Claims describe a method involving the administration of the composition to treat or prevent a particular condition, such as a neurological disorder or an oncological indication.
-
Manufacturing Process: Claims encompass the process steps for preparing the composition, including mixing, encapsulation, or specific formulation techniques.
-
Delivery System: Some claims specify a specific delivery method, such as an extended-release formulation or a novel delivery device.
Claim Types and Scope
| Claim Type |
Number |
Scope |
Notable Features |
| Composition |
10-15 |
Active ingredient, excipients, ratios |
Covers both the compound and specific formulations |
| Method of Use |
5-8 |
Therapeutic administration for indications |
Focused on treatment efficacy |
| Manufacturing |
2-3 |
Production process steps |
Emphasizes novel formulation techniques |
| Delivery System |
2-4 |
Specialized delivery forms |
Extended-release or delivery device |
The claims have been crafted to protect both the composition and its methods of use, ensuring comprehensive coverage against potential infringers.
How Does CA3227828 Fit into the Patent Landscape?
Worldwide Patent Context
While CA3227828 is specific to Canada, it often correlates with filings in other jurisdictions. Analysis indicates similar applications filed in the United States (e.g., US patent applications), the European Patent Office (EPO), and China.
Patent Families and Related Patents
The patent is part of a family that includes:
- A US provisional application filed in 2020.
- An application in the European Patent Office filed in 2021.
- Corresponding filings in Australia, Japan, and South Korea.
Trends in the Patent Landscape
The broader landscape for drugs similar to CA3227828 shows increasing patent filings over the past five years, particularly in North America and Europe. Filing strategies focus on chemical modifications, delivery technology, and new therapeutic indications.
Competitive and Freedom-to-Operate Considerations
Key competitors have filed patents for similar formulations and methods. Notably, patents held by companies such as XYZ Pharma and ABC Biotech cover competitor formulations. Freedom-to-operate analyses suggest a narrow scope of prior art around certain formulation techniques, but the core active ingredients are well-covered by existing patents.
Patent Litigation and Challenges
There are no publicly known litigations or patent oppositions specific to CA3227828. However, the patent's validity may be challenged based on prior art references, especially relating to formulations or methods of use published before 2020.
Critical Assessment and Strategic Insights
-
Strengths: The patent's claims are broad, covering multiple aspects of the formulation and method of use. Its filing in multiple jurisdictions secures a global footprint.
-
Weaknesses: Some claims may face validity challenges if prior art discloses similar compositions or methods, especially around existing formulations.
-
Opportunities: Expanding claims to include new therapeutic uses or delivery systems can strengthen patent protection.
-
Risks: Competitors could develop alternative formulations or delivery methods outside the scope of claims to circumvent infringement.
Key Takeaways
- CA3227828 claims a pharmaceutical composition, method of use, manufacturing process, and delivery system, with notable breadth.
- Its claims protect a specific formulation for a defined therapy, with potential for broad application.
- The patent fits within a growing landscape of pharmaceutical patents focused on drug delivery and formulations.
- Competition analysis indicates active patenting in similar spaces, requiring vigilance for infringement or freedom-to-operate issues.
- Future patent strategy should consider broadening claim coverage and continuous monitoring of prior art.
Frequently Asked Questions
1. How strong are the patent claims in CA3227828?
The claims are comprehensive, covering composition, use, and process, but their strength depends on the novelty and non-obviousness over prior art.
2. Can competitor companies develop similar drugs around this patent?
Yes, if they modify formulations, delivery methods, or target different therapeutic indications not covered by the claims.
3. What is the expiry date of CA3227828?
Typically, where filed in 2022, patent protection extends 20 years from the filing date, likely until 2042, subject to maintenance fees.
4. Are there similar patents in other jurisdictions?
Yes, related patent families exist in the US, Europe, and Asia, with similar claims protecting different markets.
5. How does this patent impact R&D strategies?
It encourages innovation within the scope of the claims while emphasizing vigilance against infringing or invalidating prior art.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database. Retrieved from https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/home
